Evidence map›Paper›PMID 40653540›Full record

ArticleScientific reports2025

TransPRK in the treatment of low to moderate and high myopia: a comparative study of the clinical outcomes.

Zhanhua Shi, Mingjun Gao, Changyang Liu, Siqi Zhang, Qi Zhao

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Corneal clarity and biomechanical stability after mitomycin C-assisted photorefractive keratectomy in low, moderate, and high myopia.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhanhua ShiDepartment of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, 116000, China.
Mingjun GaoDepartment of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, 116000, China.
Changyang LiuDepartment of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, 116000, China.
Siqi ZhangDepartment of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, 116000, China.
Qi ZhaoDepartment of Ophthalmology, The Second Hospital of Dalian Medical University, Dalian, 116000, China. 1526579367@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to compare the refractive parameters and visual quality of patients with low to moderate myopia and high myopia before and after transepithelial photorefractive keratectomy(transPRK)to evaluate the efficacy and safety of transPRK in correcting different degrees of myopia, and to explore the impact of the surgery on the visual quality of patients with different spherical equivalent(SER). This study retrospectively included myopic patients who underwent transPRK using the Schwind Amaris excimer laser. The patients were divided into the low to moderate and high myopia groups according to the preoperative spherical equivalent. The subjects' refractive parameters and visual quality before, at 1, 3, and 6 months after surgery were collected and analysed. The changes in each value before and after surgery (Δ) were compared. At 6 months after surgery, 96.8% (low to moderate myopia group) and 92.3% (high myopia group) of the eyes in both groups achieved uncorrected distance visual acuity (UDVA) of 20/20 or above. At 6 months after surgery, 65.1% of the eyes in the low to moderate myopia group had SER within ± 0.5D, and 95.2% had SER within ± 1.0D. In the high myopia group, 71.8% of the eyes had SER within ± 0.5D, and 97.4% had SER within ± 1.0D. No patient lost one or more lines of corrected distance visual acuity (CDVA) simultaneously after surgery. All patients achieved a CDVA of 20/20 after surgery. There were significant differences in △corneal higher-order aberrations at 6.0 mm pupil(C.HOA), △corneal spherical aberration at 6.0 mm pupil(C.Sph), and △corneal coma aberration at 6.0 mm pupil(C.Coma) between the two groups (P < 0.05). In comparison, there were no significant differences in △corneal trefoil aberration at 6.0 mm pupil(C.Tre), △and the strehl ratio(SR) between the two groups (P > 0.05). There were significant differences in △central corneal thickness (CCT), △anterior surface asphericity of the cornea (Q), △eccentricity (e) and △corneal curvature (K1, K2, and Km) between the two groups (P < 0.001). In the low to moderate myopia group, △SER was positively correlated with △C.HOA and △C.Sph (P < 0.01), and △SER was positively correlated with △C.Coma at 6 months (P < 0.01); there was no correlation between △SER and △C.Tre and △SR (P > 0.05). In the high myopia group, △SER was positively correlated with △C.HOA at 6 months (P < 0.05); △SER was positively correlated with △C.Sph and △SR at 3 and 6 months (P < 0.05). There was no correlation between △SER and △C.Coma or △C.Tre (P > 0.05). This study demonstrates that transPRK can safely and effectively correct the UDVA and refractive status of patients with low to moderate and high myopia. Compared with patients with low to moderate myopia, patients with high myopia have more increases in C.HOA, C.Sph, and C.Coma at the same time point after surgery.△SER is positively correlated with △C.HOA after surgery. Among the three aberrations, the correlation between △SER and △C.Sph is the strongest in the high myopia group simultaneously.

Indexed as

MyopiaPhotorefractive KeratectomyAdultFemaleHumansLasers, ExcimerMaleMiddle AgedRefraction, OcularRetrospective StudiesTreatment OutcomeVisual AcuityYoung AdultDiopterTransPRKVisual quality

Identifiers

PMID40653540
PMCPMC12256593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.